Biogen Inc. is a global biotechnology company based in Massachusetts that develops medicines for neurological and other disorders. Its filings show it lobbies Congress on Medicare and Medicaid matters, including Medicare Part B and Part D drug coverage, and on pharmaceutical industry issues. It has reported $200,000 in lobbying and used the firm Jeffrey J. Kimbell & Associates.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
DAVID RUDLOFF
The latest disclosures for this client.
JEFFREY J. KIMBELL & ASSOCIATES, INC.
4@JEFFREY J. KIMBELL & ASSOCIATES, INC.
4TThe entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
JEFFREY J. KIMBELL & ASSOCIATES, INC.
JOHN HERZOG
JEFFREY J. KIMBELL & ASSOCIATES, INC.
JOHN R RAY
JEFFREY J. KIMBELL & ASSOCIATES, INC.
KEITH STUDDARD
JEFFREY J. KIMBELL & ASSOCIATES, INC.
LAURA KEMPER
JEFFREY J. KIMBELL & ASSOCIATES, INC.
mr JEFFREY J KIMBELL
JEFFREY J. KIMBELL & ASSOCIATES, INC.
mr KENNETH LEE HODGE
JEFFREY J. KIMBELL & ASSOCIATES, INC.
BRETT MEEKS
JEFFREY J. KIMBELL & ASSOCIATES, INC.
JEFFREY J. KIMBELL & ASSOCIATES, INC.
Q3JEFFREY J. KIMBELL & ASSOCIATES, INC.
Q2JEFFREY J. KIMBELL & ASSOCIATES, INC.
Q1